Calcific Aortic Stenosis Clinical Trial
Official title:
Effective Management of Calcific Aortic Stenosis in the Elderly
Although aortic valve replacement is recommended for any symptomatic severe calcific aortic
stenosis, the therapeutic decision may be difficult. because of patient age and
comorbidities.
Transcatheter Aortic Valve Implantation (TAVI) has recently extended the therapeutic
indications in patients at high risk of surgery. However, the proportion of different
treatments is not known in a contemporary population that can be treated according to the
different resources currently available.
The scientific goal of this observational research is to evaluate intra-hospital therapeutic
decision in elderly patients referred because of symptomatic severe aortic stenosis.
The one-year survival will be analyzed according to the therapeutic decision and the
characteristics of the patients.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04149600 -
Identification of Genetic Causes of Calcific Aortic Valve Disease
|
||
| Completed |
NCT02132026 -
Study Investigating the Effect of Drugs Used to Treat Osteoporosis on the Progression of Calcific Aortic Stenosis.
|
Phase 2 | |
| Completed |
NCT02184442 -
The PARTNER II Trial: Placement of AoRTic TraNscathetER Valves - PII B
|
N/A |